Invention Grant
- Patent Title: Griseofulvin compound
-
Application No.: US18046270Application Date: 2022-10-13
-
Publication No.: US11834427B2Publication Date: 2023-12-05
- Inventor: Keiji Saito , Katsuyoshi Nakajima , Toru Taniguchi , Osamu Iwamoto , Satoshi Shibuya , Yasuyuki Ogawa , Kazumasa Aoki , Nobuya Kurikawa , Shinji Tanaka , Momoko Ogitani , Eriko Kioi , Kaori Ito , Natsumi Nishihama , Tsuyoshi Mikkaichi , Wataru Saitoh
- Applicant: Daiichi Sankyo Company, Limited
- Applicant Address: JP Tokyo
- Assignee: Daiichi Sankyo Company, Limited
- Current Assignee: Daiichi Sankyo Company, Limited
- Current Assignee Address: JP Tokyo
- Agency: Myers Bigel, P.A.
- Priority: JP 16067076 2016.03.30
- Main IPC: C07D307/94
- IPC: C07D307/94 ; C07D405/04 ; C07D405/10 ; C07D407/12 ; C07D413/04 ; C07D413/14 ; A61K31/343 ; A61K31/4155 ; A61K31/4245 ; C07D413/10
Abstract:
An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.
wherein the symbols in the formula are defined below:
R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group;
A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.
wherein the symbols in the formula are defined below:
R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group;
A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
Public/Granted literature
- US20230136988A1 GRISEOFULVIN COMPOUND Public/Granted day:2023-05-04
Information query
